NCT03255070 2024-02-01A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)Ambrx, Inc.Phase 1 Completed106 enrolled
NCT01605318 2024-01-24Study of Labetuzumab Govitecan in Participants With Metastatic Colorectal CancerGilead SciencesPhase 1/2 Terminated92 enrolled
NCT01915472 2021-08-19A Phase II Study of IMMU 130 in Patients With Metastatic Colorectal CancerGilead SciencesPhase 2 Withdrawn